Dr Axel Merseburger joins Dr Enrique Grande to cover the rapid evolution of the treatment landscape of mUC, including recent data updates in first-line, maintenance therapy, and second- and later-treatment lines. Dr Merseburger also discusses treatment sequencing, combination strategies that could change clinical practice, factors influencing treatment selection, and management of adverse events with Dr Maria Jose Juan-Fita.
Click on the CC icon to select French, Spanish, Portuguese, German, or Japanese subtitles.